Hongxin Deng

4.8k total citations
128 papers, 2.3k citations indexed

About

Hongxin Deng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hongxin Deng has authored 128 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 41 papers in Oncology and 33 papers in Immunology. Recurrent topics in Hongxin Deng's work include Immunotherapy and Immune Responses (20 papers), RNA Interference and Gene Delivery (18 papers) and Angiogenesis and VEGF in Cancer (15 papers). Hongxin Deng is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), RNA Interference and Gene Delivery (18 papers) and Angiogenesis and VEGF in Cancer (15 papers). Hongxin Deng collaborates with scholars based in China, United States and United Kingdom. Hongxin Deng's co-authors include Yuquan Wei, Lei Dai, Dechao Yu, Xia Zhao, Xiaolan Su, Lin Cheng, Shuang Zhang, Zhiyong Qian, Lijuan Chen and Jiong Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hongxin Deng

125 papers receiving 2.2k citations

Peers

Countries citing papers authored by Hongxin Deng

Since Specialization

Citations

This map shows the geographic impact of Hongxin Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxin Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxin Deng more than expected).

Fields of papers citing papers by Hongxin Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxin Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxin Deng. The network helps show where Hongxin Deng may publish in the future.

Co-authorship network of co-authors of Hongxin Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxin Deng. A scholar is included among the top collaborators of Hongxin Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxin Deng. Hongxin Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preconditioning With TGF‐β Inhibitors Enhances Therapeutic Efficacy of Endothelial Progenitor Cells for Wound Healing in Diabetic Mice 2025 ·MedComm ·(unknown), Fuyi Cheng, Qingyuan Jiang, Yong Zhang, Fei Du, Cheng Pan, (unknown), (unknown), (unknown), Huilin Wang, (unknown), Xiaolan Su, Hongxin Deng	0
2	A 3D-printed microdevice encapsulates vascularized islets composed of iPSC-derived β-like cells and microvascular fragments for type 1 diabetes treatment 2024 ·Biomaterials ·(unknown), Wenshuang Wang, (unknown), Haofan Liu, Jing Luo, (unknown), (unknown), (unknown), Gang Shi, Fuyi Cheng, Xiaolan Su, Lei Dai, Maling Gou, Hongxin Deng	5
3	Characterizing neuroinflammation and identifying prenatal diagnostic markers for neural tube defects through integrated multi-omics analysis 2024 ·Journal of Translational Medicine ·Wenshuang Wang, Yanhong Ji, (unknown), Zheran Liu, (unknown), Lei Dai, Xiaolan Su, Qingyuan Jiang, Hongxin Deng	3
4	CAR-NK cell therapy for glioblastoma: what to do next? 2023 ·Frontiers in Oncology ·(unknown), Jiao Zhu, Yong Zhang, Hongxin Deng	19
5	Mitochondrial UQCC3 controls embryonic and tumor angiogenesis by regulating VEGF expression 2023 ·iScience ·(unknown), (unknown), Yunsheng Yang, (unknown), Lingcheng Chen, Hui Luo, Jian Zhong, (unknown), Fengzhu Guo, Gan Jia, (unknown), Lin Xu, Qiqi Li, (unknown), (unknown), (unknown), Rong Li, Hongxin Deng, (unknown)	4
6	Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler 2022 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Jing Su, (unknown), Ruiting Li, (unknown), Xiaomei Zhong, Li Song, Yi Liu, (unknown), Hongxin Deng, Yuquan Wei, Yang Yang	7
7	In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system 2021 ·Molecular Therapy — Methods & Clinical Development ·Qian Li, Jing Su, Yi Liu, (unknown), Xiaomei Zhong, (unknown), Qingnan Wang, Hongxin Deng, Yang Yang	33
8	SARI prevents ocular angiogenesis and inflammation in mice 2020 ·Journal of Cellular and Molecular Medicine ·Wenqiu Zhang, Lei Dai, Xun Li, Yiming Li, Maurice Yap, Longqian Liu, Hongxin Deng	3
9	CRISPR-Cas9-Mediated In Vivo Gene Integration at the Albumin Locus Recovers Hemostasis in Neonatal and Adult Hemophilia B Mice 2020 ·Molecular Therapy — Methods & Clinical Development ·Qingnan Wang, Xiaomei Zhong, Qian Li, Jing Su, Yi Liu, (unknown), Hongxin Deng, Yang Yang	37
10	Interleukin‐35 in immune‐related diseases: protection or destruction 2019 ·Immunology ·Junfeng Zhang, Yunsheng Zhang, Qingpeng Wang, Chunlei Li, Hongxin Deng, Chuanping Si, Huabao Xiong	62
11	A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity 2016 ·Signal Transduction and Targeted Therapy ·Hongwei Tian, Gang Shi, Qin Wang, Yiming Li, Qianmei Yang, Chunlei Li, (unknown), Min Wu, Charles Xie, Shuang Zhang, Yang Yang, Rong Xiang, Dechao Yu, Yuquan Wei, Hongxin Deng	43
12	Correction: NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin 2012 ·PLoS ONE ·(unknown), Xinyu Zhao, Lei Li, (unknown), (unknown), (unknown), Xinyu Liu, Chunlai Nie, Lei Liu, Aiping Tong, Hongxin Deng, Jiong Li, (unknown), Yuquan Wei	1
13	Combination of Caspy2 and IP-10 Gene Therapy Significantly Improves Therapeutic Efficacy Against Murine Malignant Neoplasm Growth and Metastasis 2012 ·Human Gene Therapy ·Na Zhang, Yang Yang, Lin Cheng, Xiaomei Zhang, Shuang Zhang, Wei Wang, Shengyong Liu, Shuya Wang, (unknown), Wenjing Xu, Lei Dai, (unknown), Ping Fan, Lixia Dai, Hongwei Tian, Lei Liu, Hongxin Deng	11
14	Intravenous liposomal delivery of the short hairpin RNAs against Plk1 controls the growth of established human hepatocellular carcinoma 2011 ·Cancer Biology & Therapy ·Hongxin Deng, Qingyuan Jiang, Yang Yang, Shuang Zhang, Yongping Ma, Gang Xie, Xiang Chen, Zhiyong Qian, Yanjun Wen, Jiong Li, (unknown), Lijuan Chen, Xia Zhao, Yuquan Wei	10
15	Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice 2009 ·Clinical Cancer Research ·Yongsheng Wang, Dan Li, Shi H, Yanjun Wen, Li Yang, Ning Xu, Xiancheng Chen, (unknown), Ping Chen, Jiong Li, Hongxin Deng, Chunting Wang, Gary Xie, (unknown), Yong-Qiu Mao, Lijuan Chen, (unknown), Yuquan Wei	49
16	RNA Interference-Mediated Silencing of the Phosphatidylinositol 3-Kinase Catalytic Subunit Attenuates Growth of Human Ovarian Cancer Cells in vitroand in vivo 2009 ·Oncology ·Xi Zhang, Hongxin Deng, Xia Zhao, Dan Su, (unknown), Lijuan Chen, Yuquan Wei, Qian Zhong, Zhengyu Li, (unknown), Tao Yi	16
17	VEGF-Targeted Short Hairpin RNA Inhibits Intraperitoneal Ovarian Cancer Growth in Nude Mice 2009 ·Oncology ·Yu Bai, Hongxin Deng, Yang Yang, Xia Zhao, Yuquan Wei, Gang Xie, Zhengyu Li, Xiancheng Chen, Lijuan Chen, Yongsheng Wang, Dan Su, Zhiyong Qian, Qian Zhong, Hong Luo, Tao Yi	12
18	Efficient Inhibition of Ovarian Cancer Growth and Prolonged Survival by Transfection with a Novel Pro-Apoptotic Gene, hPNAS-4, in a Mouse Model 2008 ·Oncology ·Fan Yang, Zhengyu Li, Hongxin Deng, Hanshuo Yang, Fei Yan, Zhiyong Qian, Lijuan Chen, Yuquan Wei, Xia Zhao	11
19	Synthesis, characterization and hydrolytic degradation study of polyetheresteramide copolymers based on ε-caprolactone, 6-aminocaproic acid, and poly(ethylene glycol) 2007 ·Journal of Materials Science Materials in Medicine ·(unknown), Zhiyong Qian, (unknown), Meijuan Huang, (unknown), Changyang Gong, Hongxin Deng, (unknown), Jinliang Yang, Maling Gou, TU Ming-jing	2
20	Immunogene Therapy of Tumors with Vaccine Based on Xenogeneic Epidermal Growth Factor Receptor 2003 ·The Journal of Immunology ·You Lü, Yuquan Wei, Ling Tian, Xia Zhao, Li Yang, (unknown), Bin Kan, Yanjun Wen, Feng Liu, Hongxin Deng, Jiong Li, Yong-Qiu Mao, Lei Song, Meijuan Huang, Feng Peng, Yu Jiang, Hao Zhou, Liqun Zhou, Feng Luo	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact